We are live on
!
Find out more
FBB
Fulton Breakefield Broenniman Portfolio holdings
AUM
$1.53B
1-Year Est. Return
18.11%
This Fund
S&P 500
This Quarter
Est. Return
+0.76%
1 Year Est. Return
+18.11%
3 Year Est. Return
+57.23%
5 Year Est. Return
+68.56%
10 Year Est. Return
+240.26%
AUM
$341M
AUM Growth
–
Cap. Flow
+$345M
Cap. Flow
% of AUM
101.26%
Top 10 Holdings %
Top 10 Hldgs %
19.59%
Holding
132
New
132
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$7.42M |
| 2 |
Verizon
VZ
|
+$6.96M |
| 3 |
GE Aerospace
GE
|
+$6.92M |
| 4 |
IBM
IBM
|
+$6.91M |
| 5 |
Johnson & Johnson
JNJ
|
+$6.9M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.5% |
| 2 | Consumer Staples | 10.3% |
| 3 | Consumer Discretionary | 10.14% |
| 4 | Industrials | 8.94% |
| 5 | Energy | 8.6% |
Similar funds
SG
FI
HR
MCP
CCM
CCP
ICM
GHC
Fulton Breakefield Broenniman's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Fulton Breakefield Broenniman, which disclosed 132 positions worth $341M. Its ten largest holdings account for 20% of the portfolio.
Its largest position is Pfizer: 268,454 shares worth $7.13M.
By sector, the portfolio is most concentrated in Healthcare at 10% of assets, followed by Consumer Staples and Consumer Discretionary.
- Fulton Breakefield Broenniman's largest Q2 2013 buy was Pfizer: 268,454 shares worth $7.13M.
- Fulton Breakefield Broenniman's ten largest holdings make up 20% of its $341M portfolio in Q2 2013.
- Fulton Breakefield Broenniman disclosed 132 positions in Q2 2013, its first 13F filing on record.
Based on Fulton Breakefield Broenniman's 13F filing for Q2 2013, filed 7 Aug 2013.